2022 Infectious Disease Board Review Course

McLean, VA US

The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams, and additional study guides and primers. Learners not taking the board exam will find the course provides a comprehensive and practical update on common topics and challenges in infectious diseases.

Learning Objectives

 
At the conclusion of this activity, participants will be able to:
 
  • Identify gaps in infectious diseases medical knowledge where further study is needed for board preparation and patient management
  • Improve confidence for taking the initial certification exam or one of the maintenance of certification assessment options
  • Identify strategies for integrating diagnostic results and patient symptoms to accurately diagnose infectious diseases
  • Recommend appropriate treatment options for infectious disease patients
  • Assess risk, determine prognosis, and apply principles from epidemiologic studies
  • Identify best-practice guidelines to incorporate into the care of infectious disease patients
  • Answer questions written in the specific format used by the ABIM for the certification and recertification examinations
Course summary
Available credit: 
  • 117.00 ABIM MOC 2
  • 117.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 117.00 Completion
Course opens: 
12/01/2021
Course expires: 
12/31/2023
Cost:
$1,450.00
The Ritz-Carlton, Tysons Corner
1700 Tysons Boulevard
McLean, VA 22102
United States
+1 (703) 506-4300

The Ritz-Carlton, Tysons Corner

The Ritz-Carlton, Tysons Corner is located in McLean, one of Northern Virginia's most desirable neighborhoods, our luxury hotel is connected to high-end shopping at Tysons Galleria and is a short distance from the iconic landmarks of downtown Washington, D.C. 

Room Reservations

  • Group Rate: US $185.00 per night, plus 13% room tax 
  • Cancellations are permitted 72 hours prior to arrival to avoid cancellation penalty of one night’s room and tax fee.
  • Reservations can be booked directly through the room reservations link below or calling +1-703-744-3947 and refer to group name (Infectious Disease Board Review 2022) or book your guestroom reservations by using the group discount booking link:
    2022 IDBR Room Reservations Link
  • All reservations should be received by the Hotel no later than Monday, August 1, 2022

Check-in | Check Out

  • Check-in:   4:00 PM
  • Checkout: 11:00 AM

Logistical Inquiries

If you have any additional questions about your hotel booking or other logistical arrangements, please email your inquiries to cehp@gwu.edu.

COURSE DIRECTORS 

 
John Bennett, MD*
Bethesda, Maryland
 
 
 
 
 
Henry Masur, MD*
Bethesda, Maryland
 

 

 

CO-DIRECTORS 

 
Paul Auwaerter, MD
Clinical Director, Division of Infectious Diseases, Johns Hopkins Hospital
Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, Maryland
               
 
 
David Gilbert, MD
Chief of Infectious Diseases, Providence Portland Medical Center
Director, Earle A. Chiles Research Center, Providence Portland Medical Center
Professor of Medicine, Oregon Health & Science University
Portland, Oregon
               
 
Roy Gulick, MD, MPH
Professor of Medicine, Weill Cornell Medical College
Chief, Division of Infectious Diseases, Weill Cornell Medical College
Gladys and Roland Harriman Professor of Medicine, Weill Cornell Medical College
New York, New York
               
 
Kieren A. Marr, MD
Director, Transplant and Oncology Infectious Diseases, John Hopkins University School of Medicine
Professor of Medicine and Oncology, John Hopkins University School of Medicine
Baltimore, Maryland
 
 
 
Andrew Pavia, MD
Chief, Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center
George and Esther Gross Presidential Professor, University of Utah School of Medicine
Salt Lake City, Utah

 
 
 
Richard Whitley, MD
Co-Director, Pediatric Infectious Diseases, Children’s Hospital of Alabama
Loeb Eminent Scholar Chair in Pediatrics, Distinguished Professor of Pediatrics,
Professor of Microbiology, Medicine, and Neurosurgery,
University of Alabama at Birmingham
Birmingham, Alabama
 

FACULTY 

 

Barbara D. Alexander, MD, MHS
Director, Transplant Infectious Diseases Service, Duke University Medical Center
Associate Professor of Medicine and Pathology, Duke University School of Medicine
Durham, North Carolina

 
 
David M. Aronoff, MD, FIDSA
Professor & Addison B. Scoville Jr. Chair in Medicine
Director, Division of Infectious Diseases
Vanderbilt University Medical Center Nashville, Tennessee
 
 
 
Taison Bell, MD
Assistant Professor of Medicine, School of Medicine, University of Virginia
Charlottesville, Virginia
 
 
 
 
Karen Bloch, MD
Associate Professor, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee
 
 
 
Helen Boucher, MD
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts
 
 
 
Henry F. Chambers, MD
Professor of Medicine, University of California San Francisco
Chief, Division of Infectious Diseases, San Francisco General Hospital
Professor of Medicine, University of California San Francisco
San Francisco, California

 
Shireesha Dhanireddy, MD
Assistant Medical Director, Madison Clinic
Harborview Medical Center
Seattle, Washington
 
 
 
Susan Dorman, MD
Professor, Division of Infectious Diseases
College of Medicine, Medical University of South Carolina
Charleston, South Carolina
 
 
 
Herbert DuPont, MD
Chief, Internal Medicine
The University of Texas-Houston Medical School
Houston, Texas
 
 
 
Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Director, Harvard Center for AIDS Research Clinical Core, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts
 
 
Khalil G. Ghanem, MD, PhD
Deputy Director of Education, Department of Medicine
Johns Hopkins Bayview Medical Center
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Steven M. Holland, MD *
Bethesda, Maryland
 
 
 

 

Michael Klompas, MD
Professor of Medicine, Division of Infectious Diseases
Brigham and Women's Hospital
Harvard Pilgrim Health Care Institute
Boston, Massachusetts
 
 
Camille Kotton, MD
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
 
 
Frank Maldarelli, MD, PhD *
Bethesda, Maryland
 
 
 
 
Edward Mitre, MD
Bethesda, Maryland
 
 
 
 
 
Sandra Nelson, MD
Massachusetts General Hospital
Boston, Massachusetts
 
 
 
 
Stacey Rubin Rose, MD, FACP
Assistant Professor, Department of Infectious Diseases
Assistant Dean of Clinical Curriculum, School of Medicine
Baylor College of Medicine
Houston, Texas
 
 
Robin Patel, MD
Chair, Division of Clinical Microbiology
Consultant, Divisions of Clinical Microbiology and Infectious Diseases
Professor of Medicine and Microbiology, Mayo Clinic
Rochester, Minnesota
 
Michael S. Saag, MD
Director, Center for AIDS Research, University of Alabama at Birmingham
Professor of Medicine, Director of UAB CFAR, Jim Straley Chair in AIDS Research, University of Alabama at Birmingham
Birmingham, Alabama
 
 
David L. Thomas, MD, MPH
Chief of Infectious Diseases, Johns Hopkins School of Medicine
Stanhope Bayne Jones Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, Maryland
 
 
 
Allan R. Tunkel, MD, PhD
Associate Dean, Warren Alpert Medical School of Brown University
Providence, Rhode Island
 
 
 
 
Kevin Winthrop, MD, MPH
Associate Professor of Infectious Diseases, Ophthalmology
Professor of Public Health and Preventive Medicine
Division of Infectious Diseases, OHSU
Portland, Oregon
 
 
*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the course, although the NIH is not an official sponsor. The views expressed by the participants do not necessarily represent the opinions of the NIH, DHHS, or the Federal Government.
**Subject to change
Faculty(s)

Barbara Alexander, MD, MHS

has a financial relationship (Advisor) with HealthTrackRx;.
has a financial relationship (Researcher) with Cidara;.
has a financial relationship (Researcher) with Shire/Takeda;.
has a financial relationship (Consultant) with F2G;.
has a financial relationship (Consultant) with Scynexis;.

David Aronoff, MD, FIDSA, FAAM

has a financial relationship (Advisor) with Cepheid;.

Paul Auwaerter

has no relevant financial relationships to disclose at this time.

Taison Bell, MD, MBA

has no relevant financial relationships to disclose at this time.

Karen Bloch, MD MPH

has no relevant financial relationships to disclose at this time.

Helen Boucher, MD

has a financial relationship (Consultant) with Elsevier;.
has a financial relationship (Consultant) with ASM;.
has a financial relationship (Consultant) with Sanford Guide;.

Henry Chambers

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Shireesha Dhanireddy

has no relevant financial relationships to disclose at this time.

Susan Dorman

has no relevant financial relationships to disclose at this time.

Herbert DuPont, MD

has no relevant financial relationships to disclose at this time.

Rajesh Gandhi, MD

has no relevant financial relationships to disclose at this time.

Khalil Ghanem, MD, PhD

has no relevant financial relationships to disclose at this time.

David Gilbert

has no relevant financial relationships to disclose at this time.

ROY GULICK, MD, MPH

has no relevant financial relationships to disclose at this time.

Steven Holland, MD

has no relevant financial relationships to disclose at this time.

Michael Klompas, MD, MPH

has a financial relationship (Royalties or Patent Beneficiary) with UpToDate;.

Camille Kotton, MD, FIDSA, FAST

has a financial relationship (Consultant) with Takeda;.
has a financial relationship (Advisor) with Evrys;.
has a financial relationship (Consultant) with Merck;.
has a financial relationship (Consultant) with Hookipa;.
has a financial relationship (Advisor) with Roche Diagnostics;.
has a financial relationship (Consultant) with Natera;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Beigene;.
has a financial relationship (Speaker) with Oxford Immunotec;.
has a financial relationship (Advisor) with ResTORBio;.

Frank Maldarelli

has no relevant financial relationships to disclose at this time.

Kieren Marr

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Edward Mitre

has no relevant financial relationships to disclose at this time.

Sandra Nelson, MD

has no relevant financial relationships to disclose at this time.

Robin Patel, MD

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Andrew Pavia, M.D.

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Stacey Rose, MD, FACP

has no relevant financial relationships to disclose at this time.

Michael Saag, MD

has no relevant financial relationships to disclose at this time.

David Thomas, MD

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Barbara Trautner, MD, PhD

has a financial relationship (Consultant) with Genentech;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Genentech;.

Allan Tunkel

has no relevant financial relationships to disclose at this time.

Richard Whitley, M.D.

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Kevin Winthrop, MD, MPH

has a financial relationship (Research Funding (if you were the principal or named investigator)) with Insmed;.
has a financial relationship (Consultant) with AN2 Therapeutics;.
has a financial relationship (Consultant) with Insmed;.
has a financial relationship (Consultant) with Spero;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Paratek;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with RedHill Biopharma;.
has a financial relationship (Consultant) with Paratek;.
has a financial relationship (Consultant) with RedHill Biopharma;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with AN2 Therapeutics;.

PHYSICIANS 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and the Infectious Disease Board Review, LLC. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
 
The George Washington University School of Medicine and Health Sciences designates this live internet activity for a maximum of 117 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

MOC 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 117 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 

PHYSICIAN ASSISTANTS

PAs may claim a maximum of 117 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 

NURSE PRACTITIONERS

For the purposes of recertification, AANPCB accepts AMA PRA Category 1 Credit™ issued by organizations accredited by ACCME as an equivalent number of hours of participation.
 

NON-PHYSICIAN CREDIT

Certificates of attendance will be provided to attendees who cannot accept AMA PRA Category 1 Credits.

Available Credit

  • 117.00 ABIM MOC 2
  • 117.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 117.00 Completion

Price

Cost:
$1,450.00
Please login or register to take this course.

 

-----------------

Registration Categories and Fees 

Registration Category
Early Bird (Ends May 1, 2022)Standard
Physicians (Live)
$1,350$1,450
Physicians (Virtual)$1,150$1,250
Physicians-in-Training: Residents & Fellows (Live)
$1,250$1,350
Physicians-in-Training: Residents & Fellows (Virtual)$1,050$1,150
Allied Health Professionals: Non-Physicians (Live)
$1,250$1,350
Allied Health Professionals: Non-Physicians (Virtual)$1,050$1,150
 
 

Syllabus & USB Drive

Syllabus Option
Price
Digital Syllabus 
Free 
Printed Syllabus 
$100.00
USB Drive
$40.00
Print Syllabus + USB Drive$140.00
  

Meeting Registration Includes

Access to the following course materials until December 31, 2023:
 
  • Pre-course online materials – board prep question banks, primers and study guides, and online only lectures (available June 15, 2022)
  • 5-day sessions – featuring faculty presentations, daily board review sessions, and faculty Q&A sessions.
  • Access to recorded lectures until December 31, 2023 (available shortly after the close of the course)
  • Digital syllabus in PDF format (printed syllabus and USB drive are available for an additional cost.
 

Accessing Course Materials

  • Pre-course Online Materials - On June 15, you will receive an email from the course with instructions for accessing the pre-course online materials.
  • Syllabus & USB Drive - If you purchase the print syllabus or USB drive with PDF files of the syllabus, you will receive them via mail the week of the live course.
     

Cancellation Policy

  • Notification of cancellation must be received in writing via cehp@gwu.edu. Registrations cannot be cancelled over the telephone.
  • Cancellations received before June 15, 2022 are eligible for a refund of 100%, less a $50 processing fee.
  • Cancellations received between June 15, 2022 and August 6, 2022 are eligible for a refund of 50%, less a $50 processing fee.
  • Tuition is not refundable after August 6, 2022.
  • Substitutions will be accepted only with written authorization from the original registrant.
  • Note: An attendee who does not cancel in writing and does not complete the course is still responsible for payment.
 

Payment by Check

 
If you selected the check option for payment, please remit your check to:
 
Office of CEHP, Attn: Sheena P. King
2300 I Street, NW
Room 112C
Washington, DC 20052 
 

Unpaid Registration Policy

All unpaid registrations must be paid by either credit card or paper check within 30 days of the date of registration. If a registration fee is unpaid after 30 days from the date of registration, the registration will be canceled.